array:19 [
  "pii" => "X0211699502027873"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2002-04-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2002;22 Supl 2:13"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2437
    "formatos" => array:3 [
      "EPUB" => 195
      "HTML" => 1935
      "PDF" => 307
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699502027865"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2002-04-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2002;22 Supl 2:14"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2870
      "formatos" => array:3 [
        "EPUB" => 188
        "HTML" => 2226
        "PDF" => 456
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Homocisteína, hipertensión arterial y genes"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "14"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. C. RODRIGUEZ PÉREZ"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. C. RODRIGUEZ PÉREZ"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699502027865?idApp=UINPBA000064"
    "url" => "/02116995/00000022000000S2/v0_201502091327/X0211699502027865/v0_201502091327/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699502027881"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2002-04-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2002;22 Supl 2:12"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1532
      "formatos" => array:3 [
        "EPUB" => 181
        "HTML" => 1026
        "PDF" => 325
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Effects of AT1 blockade on myocardial fibrosis in hypertensive heart disease. Beyond the control of blood pressure"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "12"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. DÍEZ"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. DÍEZ"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699502027881?idApp=UINPBA000064"
    "url" => "/02116995/00000022000000S2/v0_201502091327/X0211699502027881/v0_201502091327/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "Large artery damage and hypertension in end-stage renal failure (ESRD)"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "13"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "G. M. LONDON"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "G. M. LONDON"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XXII. Suplemento 2. 2002 Large artery damage and hypertension in end-stage renal failure (ESRD) G. M. London Hospital Manhes, Fleury Mérogis. France. The ill effects of hypertension are attributed to reduction in the caliber or the number of arterioles, resulting in increased total peripheral resistance (TPR). TPR is a determinant of mean arterial pressure (MBP) considered as constant over time. This does not take into account the fact that BP is an oscillatory phenomenon with systolic and diastolic BP being the limits of these oscillations. Moreover, while MBP and diastolic BP are almost constant along the arterial tree, systolic BP is amplified from the aorta to the brachial artery whose systolic BP only indirectly reflects the pressure in the aorta and LV1. The appropriate term to define the arterial factor(s) opposing LV ejection is aortic input impedance which depends on TPR, arterial compliance, wave reflections, and inertance of blood column in the arterial tree. Arterial compliance and wave reflections are major determinants of systolic and diastolic BP, and the pressure wave amplitude, i.e. pulse pressure (PP) which is an independent cardiovascular risk factor. ALTERATIONS OF AORTIC INPUT IMPEDANCE IN ESRD AND ITS CONSEQUENCES Due to anemia or arteriovenous shunts, TPR is usually within normal values in ESRD patients. The aortic impedance is increased principally due to decreased arterial compliance (arterial stiffening), increased wave reflections and higher inertance 2, 3. In ESRD changes in compliance are associated with arterial remodelling, pricipally intima-media thickening and the enlargement of arterial lumen 3. The enlargement of the arteries increases the volume and mass of blood contained in the arterial tree and is responsible for increased inertance. The increased stiffness ins renal failure is due to alterations of biomaterials characterized by increased elastic modulus (Einc) 4 associated with arterial mediacalcosis, and low-grade inflammation. Besides arterial sitffness, early wave reflections represents major contribution to LV afterload and compromised coronary perfusion 1. Wave reflections are frequently increased in es- sential hypertension and almost constantly increased in ESRD 2, 3. The arterial stiffening estimated by changes in aortic pulse wave velocity is an independent predictor of survival in ESRD and general population5-6. Increased wave reflections independently from changes in arterial stiffness are also a strong predictor of survival in ESRD patients 7. Improvement of arterial compliance and decrease in the effect of wave reflections could be obtained by antihypertensive treatment as observed with the calcium-channel blocker and ACE inhibitors 8. It has been shown that improvement of aortic compliance and use of ACE inhibitors had favorable independent effect on survival in hypertensive patients with ESRD 9. REFERENCES 1. Nichols WW, O'Rourke MF: McDonald's blood flow in arteries: theoretical, experimental and clinical principles (4th edn.). Edward Arnold, London, 1998. 2. Safar ME, London GM: The arterial system in human hypertension. In: Textbook of Hypertension (ed. Swales JD). London: Blackwell Scientific. 1994. p. 85-102. 3. London GM, Guérin AP, Marchais SJ y cols.: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50: 600-8, 1996. 4. Mourad JJ, Girerd X, Boutouyrie P y cols.: Increases stiffness of radial artery wall material in end-stage renal disease. Hypertesion 30: 1425-30, 1997. 5. Blacher J, Guérin AP, Pannier B y cols.: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99: 2434-2439, 1999. 6. Laurent S, Boutouyrie P, Asmar R y cols.: Aortic sitffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37: 1236-41, 2001. 7. London GM, Blacher J, Pannier B y cols.: Arterial wave reflections and survival in end-stage renal failure. Hypertension 38: 434-438, 2001. 8. London GM, Pannier B, Guerin AP y cols.: Cardiac hypertrophy, aortic compliance, peripheral resistance and wave reflection in end-stage renal disease: comparative effects of ACE inhibition and calcium channel blockade. Circulation 90: 2786-96, 1994. 9. Guérin AP, Blacher J, Pannier B y cols.: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103: 987-92, 2001. 13 "
    "pdfFichero" => "P7-E193-S140-A3681.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000022000000S2/v0_201502091327/X0211699502027873/v0_201502091327/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000022000000S2/v0_201502091327/X0211699502027873/v0_201502091327/en/P7-E193-S140-A3681.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699502027873?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

Large artery damage and hypertension in end-stage renal failure (ESRD)
G. M. LONDON
Leído
5300
Veces
se ha leído el artículo
1771
Total PDF
3529
Total HTML
Compartir estadísticas
 array:19 [
  "pii" => "X0211699502027873"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2002-04-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2002;22 Supl 2:13"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2437
    "formatos" => array:3 [
      "EPUB" => 195
      "HTML" => 1935
      "PDF" => 307
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699502027865"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2002-04-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2002;22 Supl 2:14"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2870
      "formatos" => array:3 [
        "EPUB" => 188
        "HTML" => 2226
        "PDF" => 456
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Homocisteína, hipertensión arterial y genes"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "14"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. C. RODRIGUEZ PÉREZ"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. C. RODRIGUEZ PÉREZ"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699502027865?idApp=UINPBA000064"
    "url" => "/02116995/00000022000000S2/v0_201502091327/X0211699502027865/v0_201502091327/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699502027881"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2002-04-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2002;22 Supl 2:12"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1532
      "formatos" => array:3 [
        "EPUB" => 181
        "HTML" => 1026
        "PDF" => 325
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Effects of AT1 blockade on myocardial fibrosis in hypertensive heart disease. Beyond the control of blood pressure"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "12"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. DÍEZ"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. DÍEZ"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699502027881?idApp=UINPBA000064"
    "url" => "/02116995/00000022000000S2/v0_201502091327/X0211699502027881/v0_201502091327/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "Large artery damage and hypertension in end-stage renal failure (ESRD)"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "13"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "G. M. LONDON"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "G. M. LONDON"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XXII. Suplemento 2. 2002 Large artery damage and hypertension in end-stage renal failure (ESRD) G. M. London Hospital Manhes, Fleury Mérogis. France. The ill effects of hypertension are attributed to reduction in the caliber or the number of arterioles, resulting in increased total peripheral resistance (TPR). TPR is a determinant of mean arterial pressure (MBP) considered as constant over time. This does not take into account the fact that BP is an oscillatory phenomenon with systolic and diastolic BP being the limits of these oscillations. Moreover, while MBP and diastolic BP are almost constant along the arterial tree, systolic BP is amplified from the aorta to the brachial artery whose systolic BP only indirectly reflects the pressure in the aorta and LV1. The appropriate term to define the arterial factor(s) opposing LV ejection is aortic input impedance which depends on TPR, arterial compliance, wave reflections, and inertance of blood column in the arterial tree. Arterial compliance and wave reflections are major determinants of systolic and diastolic BP, and the pressure wave amplitude, i.e. pulse pressure (PP) which is an independent cardiovascular risk factor. ALTERATIONS OF AORTIC INPUT IMPEDANCE IN ESRD AND ITS CONSEQUENCES Due to anemia or arteriovenous shunts, TPR is usually within normal values in ESRD patients. The aortic impedance is increased principally due to decreased arterial compliance (arterial stiffening), increased wave reflections and higher inertance 2, 3. In ESRD changes in compliance are associated with arterial remodelling, pricipally intima-media thickening and the enlargement of arterial lumen 3. The enlargement of the arteries increases the volume and mass of blood contained in the arterial tree and is responsible for increased inertance. The increased stiffness ins renal failure is due to alterations of biomaterials characterized by increased elastic modulus (Einc) 4 associated with arterial mediacalcosis, and low-grade inflammation. Besides arterial sitffness, early wave reflections represents major contribution to LV afterload and compromised coronary perfusion 1. Wave reflections are frequently increased in es- sential hypertension and almost constantly increased in ESRD 2, 3. The arterial stiffening estimated by changes in aortic pulse wave velocity is an independent predictor of survival in ESRD and general population5-6. Increased wave reflections independently from changes in arterial stiffness are also a strong predictor of survival in ESRD patients 7. Improvement of arterial compliance and decrease in the effect of wave reflections could be obtained by antihypertensive treatment as observed with the calcium-channel blocker and ACE inhibitors 8. It has been shown that improvement of aortic compliance and use of ACE inhibitors had favorable independent effect on survival in hypertensive patients with ESRD 9. REFERENCES 1. Nichols WW, O'Rourke MF: McDonald's blood flow in arteries: theoretical, experimental and clinical principles (4th edn.). Edward Arnold, London, 1998. 2. Safar ME, London GM: The arterial system in human hypertension. In: Textbook of Hypertension (ed. Swales JD). London: Blackwell Scientific. 1994. p. 85-102. 3. London GM, Guérin AP, Marchais SJ y cols.: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50: 600-8, 1996. 4. Mourad JJ, Girerd X, Boutouyrie P y cols.: Increases stiffness of radial artery wall material in end-stage renal disease. Hypertesion 30: 1425-30, 1997. 5. Blacher J, Guérin AP, Pannier B y cols.: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99: 2434-2439, 1999. 6. Laurent S, Boutouyrie P, Asmar R y cols.: Aortic sitffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37: 1236-41, 2001. 7. London GM, Blacher J, Pannier B y cols.: Arterial wave reflections and survival in end-stage renal failure. Hypertension 38: 434-438, 2001. 8. London GM, Pannier B, Guerin AP y cols.: Cardiac hypertrophy, aortic compliance, peripheral resistance and wave reflection in end-stage renal disease: comparative effects of ACE inhibition and calcium channel blockade. Circulation 90: 2786-96, 1994. 9. Guérin AP, Blacher J, Pannier B y cols.: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103: 987-92, 2001. 13 "
    "pdfFichero" => "P7-E193-S140-A3681.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000022000000S2/v0_201502091327/X0211699502027873/v0_201502091327/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000022000000S2/v0_201502091327/X0211699502027873/v0_201502091327/en/P7-E193-S140-A3681.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699502027873?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 5 6 11
2024 Octubre 29 37 66
2024 Septiembre 25 30 55
2024 Agosto 39 68 107
2024 Julio 32 32 64
2024 Junio 49 39 88
2024 Mayo 47 29 76
2024 Abril 35 25 60
2024 Marzo 24 24 48
2024 Febrero 31 45 76
2024 Enero 20 31 51
2023 Diciembre 31 25 56
2023 Noviembre 39 36 75
2023 Octubre 55 44 99
2023 Septiembre 48 29 77
2023 Agosto 26 10 36
2023 Julio 19 46 65
2023 Junio 30 16 46
2023 Mayo 34 27 61
2023 Abril 20 18 38
2023 Marzo 16 17 33
2023 Febrero 25 26 51
2023 Enero 29 22 51
2022 Diciembre 42 34 76
2022 Noviembre 35 29 64
2022 Octubre 34 36 70
2022 Septiembre 43 23 66
2022 Agosto 38 39 77
2022 Julio 43 38 81
2022 Junio 32 19 51
2022 Mayo 37 31 68
2022 Abril 21 33 54
2022 Marzo 24 27 51
2022 Febrero 23 26 49
2022 Enero 31 26 57
2021 Diciembre 21 29 50
2021 Noviembre 30 28 58
2021 Octubre 26 39 65
2021 Septiembre 20 20 40
2021 Agosto 22 30 52
2021 Julio 25 31 56
2021 Junio 12 15 27
2021 Mayo 21 27 48
2021 Abril 41 38 79
2021 Marzo 31 14 45
2021 Febrero 10 24 34
2021 Enero 17 11 28
2020 Diciembre 18 9 27
2020 Noviembre 18 11 29
2020 Octubre 14 9 23
2020 Septiembre 7 3 10
2020 Agosto 23 10 33
2020 Julio 13 12 25
2020 Junio 23 17 40
2020 Mayo 22 10 32
2020 Abril 22 14 36
2020 Marzo 33 10 43
2020 Febrero 25 18 43
2020 Enero 30 18 48
2019 Diciembre 16 11 27
2019 Noviembre 16 7 23
2019 Octubre 686 7 693
2019 Septiembre 19 8 27
2019 Agosto 4 8 12
2019 Julio 12 9 21
2019 Junio 16 8 24
2019 Mayo 6 8 14
2019 Abril 27 24 51
2019 Marzo 11 11 22
2019 Febrero 7 11 18
2019 Enero 17 6 23
2018 Diciembre 24 24 48
2018 Noviembre 47 7 54
2018 Octubre 38 11 49
2018 Septiembre 19 5 24
2018 Agosto 10 7 17
2018 Julio 12 5 17
2018 Junio 18 6 24
2018 Mayo 17 9 26
2018 Abril 14 4 18
2018 Marzo 8 4 12
2018 Febrero 12 3 15
2018 Enero 7 6 13
2017 Diciembre 12 5 17
2017 Noviembre 9 4 13
2017 Octubre 13 3 16
2017 Septiembre 5 1 6
2017 Agosto 16 6 22
2017 Julio 13 4 17
2017 Junio 20 13 33
2017 Mayo 18 4 22
2017 Abril 15 1 16
2017 Marzo 12 1 13
2017 Febrero 5 2 7
2017 Enero 6 4 10
2016 Diciembre 18 6 24
2016 Noviembre 19 7 26
2016 Octubre 37 5 42
2016 Septiembre 33 5 38
2016 Agosto 84 1 85
2016 Julio 62 0 62
2016 Junio 80 0 80
2016 Mayo 70 0 70
2016 Abril 30 0 30
2016 Marzo 24 0 24
2016 Febrero 34 0 34
2016 Enero 21 0 21
2015 Diciembre 30 0 30
2015 Noviembre 20 0 20
2015 Octubre 32 0 32
2015 Septiembre 29 0 29
2015 Agosto 19 0 19
2015 Julio 26 0 26
2015 Junio 7 0 7
2015 Mayo 12 0 12
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?